We use cookies to offer a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. By clicking accept, you consent to our privacy policy & use of cookies. (Privacy Policy)

dow jones
dow jones

Dow Jones Making Another Attempt At New Highs Above 30,000

Avatar photo
Eno Eteng (MSTA) Investment writer, Certified Financial Technician
    Summary:
  • Dow Jones is making a renewed push to break a critical resistance at 30,000 and launch into new all-time high territory, even as other US markets stutter.

The Dow Jones Industrial Average is up by 0.53% at the time of writing, after overcoming a lower open this Tuesday. US markets are under pressure as surging coronavirus cases, simmering US-China tensions, and Tesla’s large share sales are stifling any attempts by bulls to take over the market space. 

The attention of investors centers primarily on the proposed stimulus package. Feelers from the US Congress are that the stimulus package may not be as robust as March’s package, which is a disappointment to market players expecting more. This is perhaps why the Dow’s upside is struggling to gain sufficient momentum to break a critical resistance level. 

Still, the momentum lies with buyers, even as an independent study confirmed the safety of AstraZeneca’s coronavirus vaccine candidate. 

Technical Outlook for Dow Jones

Today’s price outlook focuses on the ascending triangle, whose upper boundary is now under threat from the advancing daily candle. A successful break of this area not only takes the Dow into potentially record territory (pending the break of last week’s all-time high), but also targets the 31158 price level (78.6% Fibonacci extension from the swing move of 13 May to 2 September.

On the flip side, any decline that results from lack of follow-through buying that takes out the triangle’s lower boundary, opens the door towards the 29255 support line, with 28979 and 28746 lining up as additional targets to the south.  

Dow Jones Daily Chart

Subscribe to our newsletter

I consent to the terms and conditions